An Antiviral Formulation with RNA Dependent RNA Polymerase and Viral DNA Gyrase Suppressive Features for The Treatment of Coronaviral & Adenoviral Infections NOVIR

Updated on September 1, 2021 — Creative Commons Attribution 4.0

Mas Pharmaceuticals

Mas Pharmaceuticals is a Bioceutical R&D Performing Biotechnology Company located in Istanbul , Turkey. Mas Pharmaceuticals holds the ownership of 128 Pharmaceutical and Bioceutical Patents' Exclusive License Rights which are invented by Mr. Erdal Can ALKOCLAR and Mr. Metehan YESIL. Mas…

1 datasets

Informations

License
Creative Commons Attribution 4.0
ID
5e9f437dd2bfb22b625b457e

Temporality

Frequency
Quarterly
Creation date
April 21, 2020
Latest resource update
April 21, 2020

Participate

Add a reuse Contact the producer

Embed

Permalink

Description

An Antiviral Formulation Consisting of 3 Protopanaxatriol-Class Glucopyranoside Analouges , A Semi-Synthetic Flavonol Glycoside Derivative and an Immuno-Modulatory Ginsenoside RG3 Subvariant for The Treatment of Coronaviral & Adenoviral Infections via Suppressing DNA Polymerase, RNA Dependent RNA Polymerase and Viral DNA Gyrase and Modulating Anti-Inflammatory Cytokines Tnf-Alpha, IL-6, Nf-Kappa B and PGE2 to Suppress Potential Cytokine Storms Simultaneously.

Inventors: ERDAL CAN ALKOCLAR & METEHAN YESIL

Files 3

Main file

2-viral.docx

Updated on April 21, 2020 — doc (43.0Ko) — 4 downloads

15-antiviral-eng.docx

Updated on April 21, 2020 — docx (22.2Ko) — 5 downloads

2-viral.docx

Updated on April 21, 2020 — docx (24.9Ko) — 3 downloads

Community resources 0

Publish a resource

You have built a more comprehensive database than those presented here? This is the time to share it!

No resources match your search.

Reuses 0

Add a reuse

Explore the reuses of this dataset.

Did you use this data ? Reference your work and increase your visibility.

Discussions 0

Discussion between the organization and the community about this dataset.